Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Amino Acids and Derivatives >  Tyrosine derivatives >  AG 213

AG 213

Basic information Safety Supplier Related

AG 213 Basic information

Product Name:
AG 213
Synonyms:
  • ALPHA-CYANO-3,4-DIHYDROXYTHIOCINNAMAMIDE
  • ALPHA-CYANO-(3,4-DIHYDROXY)THIOCINNAMIDE
  • AG 213
  • 3,4-DIHYDROXY-ALPHA-CYANOTHIOCINNAMAMIDE
  • (E)-2-CYANO-3-(3,4-DIHYDROXYPHENYL)-2-PROPENTHIOAMIDE
  • TYRPHOSTIN A47 99+%
  • AG 213 (Tyrphostin AG 213)
  • ZGHQGWOETPXKLY-XVNBXDOJSA-N
CAS:
122520-86-9
MF:
C10H8N2O2S
MW:
220.25
Product Categories:
  • Intracellular Signaling
  • Protein Kinase
Mol File:
122520-86-9.mol
More
Less

AG 213 Chemical Properties

Melting point:
213 °C
Boiling point:
474.5±55.0 °C(Predicted)
Density 
1.512±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
DMSO: 50 mg/mL, clear, orange
form 
Orange solid.
pka
8.82±0.10(Predicted)
More
Less

Safety Information

Hazard Codes 
Xi
Risk Statements 
36/37/38
Safety Statements 
26-36
WGK Germany 
3
10

MSDS

More
Less

AG 213 Usage And Synthesis

Description

Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs. Tyrphostins are a class of antiproliferative compounds that act as PTK blockers. PTK inhibitors which preferentially inhibit the epidermal growth factor (EGF) receptor kinase block EGF-dependent cell proliferation. AG-213 is an inhibitor of epidermal growth factor (EGF) receptor kinase with an IC50 value of 2.4 μM in the human epidermoid carcinoma cell line A431.

Uses

Tyrphostin 47 is a potent inhibitor of EGFR kinase activity.

Definition

ChEBI: 3-amino-2-[(3-hydroxy-4-oxo-1-cyclohexa-2,5-dienylidene)methyl]-3-mercapto-2-propenenitrile is a member of quinomethanes.

Biological Activity

Epidermal growth factor receptor (EGFR) and platelet-derived growth factor receptor (PDGFR) kinase inhibitor (IC 50 values are 2.4 and 3 μ M respectively). Stimulates microtubule polymerization and promotes neurite outgrowth > 17-fold over basal conditions in vitro . Also weakly inhibits protein kinase C (IC 50 = 60 μ M).

References

[1] romer l h, mclean n, turner c e, et al. tyrosine kinase activity, cytoskeletal organization, and motility in human vascular endothelial cells[j]. molecular biology of the cell, 1994, 5(3): 349-361.
[2] gazit a, yaish p, gilon c, et al. tyrphostins i: synthesis and biological activity of protein tyrosine kinase inhibitors[j]. journal of medicinal chemistry, 1989, 32(10): 2344-2352.
[3] levitzki a, gazit a. tyrosine kinase inhibition: an approach to drug development[j]. science, 1995, 267(5205): 1782.
[4] herbst r s. review of epidermal growth factor receptor biology[j]. international journal of radiation oncology biology physics, 2004, 59(2): s21-s26.

AG 213Supplier

3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
VDM Biochemicals
Tel
0330-2528181
Email
sales@vdmbio.com
BOC Sciences
Tel
16314854226
Email
info@bocsci.com
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Email
info@efebio.com
Dideu Industries Group Limited
Tel
+86-29-89586680 +86-15129568250
Email
1026@dideu.com